Author

Werner Verbiest

Observed names: Verbiest, W, W Verbiest, Werner H. A. Verbiest

Observed institutions: Goethe University Frankfurt, Janssen (Belgium), University of Liverpool, The Royal Free Hospital, St. Paul's Hospital, North Manchester General Hospital, National Institute of Allergy and Infectious Diseases, BC Centre for Excellence in HIV/AIDS, University of Birmingham

OpenAlex ID: A5057894711

A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy

2002 · Calvin J. Cohen, Susan Hunt, et al. · AIDS · 197

Baseline HIV drug resistance profile predicts response to ritonavir-saquinavir protease inhibitor therapy in a community setting

1999 · P. Richard Harrigan, Kurt Hertogs, et al. · AIDS · 116

High Prevalence of Genotypic and Phenotypic HIV-1 Drug-Resistant Strains Among Patients Receiving Antiretroviral Therapy in Abidjan, Côte d'Ivoire

2001 · Christiane Adjé, Rachanee Cheingsong, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 113

World-wide variation in HIV-1 phenotypic susceptibility in untreated individuals: biologically relevant values for resistance testing

2001 · P. Richard Harrigan, Julio S. G. Montaner, et al. · AIDS · 111

Virological and immunological analysis of a triple combination pilot study with loviride, lamivudine and zidovudine in HIV-1-infected patients

1996 · Schlomo Staszewski, Veronica Miller, et al. · AIDS · 99

Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapy

2002 · John D. Baxter, Thomas C. Merigan, et al. · AIDS · 43

Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective study

2001 · Werner Verbiest, Stephen Brown, et al. · AIDS · 19

Modest Decreases in Nnrti Susceptibility Do Not Influence Virological Outcome in Patients Receiving Initial Nnrti-Containing Triple Therapy

2003 · P Richard Harrigan, Kurt Hertogs, et al. · Antiviral Therapy · 11

A simple and rapid flow cytometric method to measure lymphocyte activation in HIV+ subjects. Diminished response to pokeweed mitogen in early disease.

1995 · E Jagers, M De Brabander, et al. · PubMed · 2

Prospective assessment of pharmacological, virological and adherence factors in antiretroviral treatment outcome (MALIBU study): adherence and attitude to medicine scores

2000 · Pillay, O, Jones, T, et al. · UCL Discovery (University College London)

P25 The relationship between ARV drug levels, drug resistance, adherence and treatment failure in a routine clinical setting

2000 · J Lloyd, C Sabin, et al. · HIV Medicine

P1 Assessing the role of treatment adherence in a clinical setting

2000 · T Jones, D Pillay, et al. · HIV Medicine

Works count: 12

Citation count: 711

H-index: 8

I10-index: 8